Billing the New Eylea Biosimilars: What Retina Practices Need to Know in 2026
What Does the Yesafili Launch Mean for Ophthalmology Billing? Yesafili (aflibercept-jbvf) is an interchangeable biosimilar to Eylea 2 mg that Biocon launched in the United
Where should we send your quote(s)?
We'll send it directly to your inbox
How many providers does your practice have?
We'll find a billing company that can support your needs
Where is your practice located?
We'll find a billing company that serves providers in your area
